Abstract: HepatologyVolume 30, Issue 1 p. 325-332 Hepatology Clinical ChallengeFree Access Primary sclerosing cholangitis Paul Angulo, Paul Angulo From the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MNSearch for more papers by this authorKeith D. Lindor M.D., Corresponding Author Keith D. Lindor M.D. [email protected] From the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MNMayo Clinic, Division of Gastroenterology and Hepatology, 200 First Street SW, Rochester, MN 55905===Search for more papers by this author Paul Angulo, Paul Angulo From the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MNSearch for more papers by this authorKeith D. Lindor M.D., Corresponding Author Keith D. Lindor M.D. [email protected] From the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MNMayo Clinic, Division of Gastroenterology and Hepatology, 200 First Street SW, Rochester, MN 55905===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510300101Citations: 188AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Lee YM, Kaplan M. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924–933. 2 Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, Twomey CK, et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98: 1594–1602. MEDLINE 3 Angulo P, DeSotel CK, Gershwin ME, Shoenfeld Y, Ahmed A, Peter J, Lindor KD. The profile and significance of serum autoantibodies in primary sclerosing cholangitis [Abstract]. Hepatology 1998; 28: 444A. 4 Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–877. MEDLINE 5 Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E. Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29: 144–752. MEDLINE 6 Duer RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Schanahan F. Neutrophil cytoplasmic antibodies: a link between sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385–1391. MEDLINE 7 Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991; 14: 1147–1152. MEDLINE 8 Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17: 411–417. MEDLINE 9 Senaldi G, Donaldson PT, Magrin S, Farrant JM, Alexander GJM, Vergani D, Williams R. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989; 97: 1430–1434. MEDLINE 10 Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples PJ, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–154. MEDLINE 11 Minuk GY, Angus M, Brickman CM, Lawley TJ, Frank MM, Hoofnagle JH, Jones EA. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985; 88: 166–170. MEDLINE 12 Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990; 98: 464–469. MEDLINE 13 Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Weish KI, Eddleston AL, et al. Amino acid substitutions at positions 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992; 16: 390–395. MEDLINE 14 Mehal WZ, Lo Y-MD, Wordsworth BP, Nauberger JM, Hubscher SC, Fleming KA, Chapman RW. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106: 160–167. MEDLINE 15 Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870–878. MEDLINE 16 Aguilar HI, Nuako K, Krom RAF, Wiesner RH. Do primary sclerosing cholangitis (PSC) patients who express HLA-DR4 haplotype have a more rapidly progressive disease? [Abstract]. Hepatology 1994; 20: 154A. 17 Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991; 13: 766–772. MEDLINE 18 Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 1992; 90: 1313–1322. MEDLINE 19 Nolan JP. Intestinal endotoxins as mediators of hepatic injury—an idea whose time has come again. Hepatology 1989; 10: 887–891. MEDLINE 20 Angulo P, Pearce DH, Johnson CD, Boynton JJ, Petersen BT, LaRusso NF, Lindor KD. Magnetic resonance cholangiopancreatogreaphy in the evaluation of the biliary tree [Abstract]. Hepatology 1998; 28: 308A. 21 Ludwig J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 11–17. MEDLINE 22 El-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SK, Williams R, Mowat AP. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226–1235. MEDLINE 23 Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St. Louis P, Griffiths AM, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995; 22: 1415–1422. MEDLINE 24 May GR, Bender CE, LaRusso NF, Wiesner RH. Nonoperative dilation of dominant strictures in patients with primary sclerosing cholangitis. Am J Roentgenol 1985; 145: 1061–1064. 25 Lee JG, Schutz SM, England RE, Leung JLU, Cotton PB. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995; 21: 661–667. MEDLINE 26 Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Wlaker S, Theilmann L. Efficacy of ursodeoxycholic acid treatment and endoscopic dilatation of major duct stenoses in primary sclerosing cholangitis. J Hepatol 1997; 26: 560–566. MEDLINE 27 Lombard M, Farrant M, Karani J, Westaby D, Williams R. Improving biliary-enteric drainage in primary sclerosing cholangitis. Gut 1991; 32: 1364–1368. MEDLINE 28 Ahrendt SA, Pitt HA, Kallo AK, Venbrux AC, Klein AS, Herlong HF, Coleman J, et al. Primary sclerosing cholangitis. Resect, dilate, or transplant? Ann Surg 1998; 227: 412–423. MEDLINE 29 Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995; 117: 146–155. MEDLINE 30 McEntee RH, Wiesner C, Cooper RJ, Washlstrom E. A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transplant Proc 1991; 23: 1563–1564. MEDLINE 31 Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451–457. MEDLINE 32 Muiesan P, Shanmugam RP, Devlin J, Rela M, Heaton ND, Saxena R, Portmann B, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Transplant Proc 1994; 26: 3574–3576. MEDLINE 33 Langnas AN, Grazi GL, Stratta RJ, Wood RP, Marujo W, Markin RS, Donovan J, et al. Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990; 85: 1136–1141. MEDLINE 34 Goss JA, Shackelton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225: 472–483. MEDLINE 35 Abu-Elmagd K, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177: 335–344. MEDLINE 36 Ismail T, Angrisani L, Powell JE, Hubscher S, Buckels J, Neuberger J, Elias E, et al. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg 1991; 78: 564–567. MEDLINE 37 Pitt HA, Thompson HH, Tompkins RK, Longmire WP. Primary sclerosing cholangitis: results of an aggressive surgical approach. Ann Surg 1982; 196: 259–266. MEDLINE 38 Cameron JL, Pitt HA, Zimer MJ, Herlong HF, Kauffman SL, Boltnott JK, Coleman J. Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg 1988; 207: 614–622. MEDLINE 39 Lindor KD. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 691–695. MEDLINE 40 Mitchell SA, Bansi D, Hunt N, Christie J, Fleming K, Chapman R. High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomized, double-blind, placebo-controlled trial [Abstract]. Gastroenterology 1997; 112: A757. 41 Helzberg JH, Peterson JM, Boyer JL. Improved survival with primary sclerosing cholangitis. Gastroenterology 1987; 92: 1869–1875. MEDLINE 42 Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–1717. MEDLINE 43 Broome U, Olsson R, Loof L, Bodemar B, Hultcrantz R, Danielsson A, Prytz W, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610–615. MEDLINE 44 Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E, et al. Hepatobiliary diseases in ulcerative colitis: an analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994; 29: 744–752. MEDLINE 45 Broome U, Lofberg R, Veress R, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: indicator of increased neoplastic potential. Hepatology 1995; 22: 1404–1408. MEDLINE 46 Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870–877. MEDLINE 47 Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E. Primary sclerosing cholangitis: a long term follow-up study. Scand J Gastroenterol 1987; 22: 655–664. MEDLINE 48 Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21–25. MEDLINE 49 Pasha TM, Petz J, Ludwig J, Therneau TM, Benson JT, Malinchoc M, Dickson ER. et al. Incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis [Abstract]. Hepatology 1997; 26: 170A. 50 Strasser S, Sheil AGR, Gallagher ND, Waugh R, McCaughan GW. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome. J Gastroenterol Hepatol 1993; 8: 238–243. MEDLINE 51 Marsh JW, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, Tzakis A, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988; 207: 21–25. MEDLINE 52 Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, Demetris AJ, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124–1125. MEDLINE 53 Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311–316. MEDLINE 54 Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68: 874–879. MEDLINE 55 Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865–869. MEDLINE 56 Jones BA, Gores GJ. Hepatobiliary malignancy. Clin Liver Dis 1998; 2: 437–449. 57 Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Ajhava E. Clinical values of serum tumor markers CEA, CA 50, and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: results from a prospective study. Anticancer Res 1992; 12: 1687–1693. MEDLINE 58 MacCarty RL, LaRusso NF, May GR, Bender CE, Wiesner RH, King JE, Coffey RJ. Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. Radiology 1985; 156: 43–46. MEDLINE 59 Campbell WL, Ferris JV, Holbert BL, Thaete FL, Baron RL. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US and MR imaging. Radiology 1998; 207: 41–50. MEDLINE 60 Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28: 700–706. MEDLINE 61 Brentnall TA, Haggit RC, Rabinovitch PS, Kimmery MB, Bronner MP, Levine DS, Kowdley KV, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331–338. MEDLINE 62 Marchesa F, Lashner BA, Lavery IC, Milsom J, Hull TL, Strong SA, Church JM, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92: 1285–1288. MEDLINE 63 Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432–440. MEDLINE 64 Choi PM, Nugent FW, Rossi RL. Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis. Gatroenterology 1992; 103: 1707–1708. 65 Nuako KW, Ahlquist DA, Snadborn WJ, Mahoney DW, Siems DM, Zinsmeister AR. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis. Cancer 1998; 82: 822–826. MEDLINE 66 Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol 1997; 27: 512–516. MEDLINE 67 Snook JA, Kelly P, Chapman RP, et al. Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis. Gut 1989; 30: 243–245. MEDLINE 68 Angulo P, Therneau TM, Jorgensen RA, DeSotel CK, Egan KS, Dickson ER, Hay JE, et al. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998; 29: 729–735. MEDLINE 69 Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995; 211: 389–392. 70 Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RAF, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991; 14: 257–261. MEDLINE 71 Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991; 23: 1462–1465. MEDLINE 72 Wiesner RH, LaRusso NF, Dozois RR, Beaver SJ. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 1986; 90: 316–322. MEDLINE 73 Kartheuser AH, Dozois RR, LaRusso NF, Wiesner RH, Ilstrup DM, Schleck CD. Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. Mayo Clin Proc 1996; 71: 748–756. MEDLINE 74 Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–436. MEDLINE 75 Hermann R, Dooley JS, Sherlock S, McIntyre N. Natural history and mortality in primary sclerosing cholangitis [Abstract]. Gut 1988; 29: A1430. 76 Broome U, Glaumann H, Hellers G, Nilson B, Sorstad J, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow-up study in the county of Stockholm. Gut 1994; 35: 84–89. MEDLINE 77 Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893–1901. MEDLINE 78 Kim WR, Lindor KD, Poterucha JJ, Benson JT, Therneau TM, Dickson ER. The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis [Abstract]. Gastroenterology 1998; 114: A1274. 79 Shetty K, Ribicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25: 1049–1053. MEDLINE 80 Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplant Surg 1997; 3: 628–637. 81 Kilpe VE, Krakauser H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to medicare. Transplantation 1993; 56: 554–561. MEDLINE 82 Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, Pichlmayr R. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996; 23: 1105–1111. MEDLINE 83 Ward EM, Kiely MJ, Maus TP, Wiesner RH, Krom RAF. Hilar biliary strictures after liver transplantation: cholangiography and percutaneous treatment. Radiology 1990; 177: 259–263. MEDLINE 84 Loftus EV, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RAF, Zinsmeister AR, Graziadei IW, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27: 685–690. MEDLINE 85 UNOS Scientific Registry. Patients waiting for transplant. UNOS Bull 1997; 2: 9–10. 86 Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, LaRusso NF, Steers JL, et al. Strong evidence for recurrence of primary sclerosing cholangitis after liver transplantation [Abstract]. Hepatology 1997; 26: 176A. 87 Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR 1993; 161: 297–300. 88 Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 1994; 191: 735–740. MEDLINE 89 Feller RB, Waugh RC, Selby WS, Dolan PM, Sheil AGR, McCaughan GW. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes. J Gastroenterol Hepatol 1996; 11: 21–25. MEDLINE 90 Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis. Hepatology 1994; 20: 356–361. MEDLINE 91 Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995; 19: 81–90. MEDLINE Citing Literature Volume30, Issue1July 1999Pages 325-332 ReferencesRelatedInformation